What is MPP Group?
MPP Group LLC is a specialized provider of drug development services, focusing on assisting clients in achieving their drug discovery objectives within the pharmaceutical industry. The company leverages a team of seasoned research scientists, including notable figures like Dr. Michael Major, who has a proven history in developing FDA-approved generic injectables. MPP Group's comprehensive service portfolio encompasses injectable drug development, analytical services, and dedicated research and development initiatives, all supported by state-of-the-art instrumentation and rigorous testing methodologies. Their commitment lies in refining processes and delivering superior drug formulations to enhance patient outcomes.
How much funding has MPP Group raised?
MPP Group has raised a total of $320K across 2 funding rounds:
Debt
$150K
Debt
$170K
Debt (2020): $150K with participation from PPP
Debt (2021): $170K led by PPP
Key Investors in MPP Group
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MPP Group?
With the recent influx of capital, MPP Group is positioned for accelerated growth and expansion in its late-stage development capabilities. This strategic financing is expected to fuel further advancements in their injectable drug development pipeline and enhance their analytical service offerings. The company's focus on generic injectables and its experienced scientific team suggest a trajectory aimed at capturing a larger share of the pharmaceutical market, potentially through strategic partnerships or expanded service contracts. The substantial backing indicates confidence from investors in MPP Group's business model and its capacity to deliver high-quality pharmaceutical solutions.
See full MPP Group company page
